| RS1558680405 |
HAAO
|
Health Risk |
Pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS1558681020 |
ATP6V1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Renal tubular acidosis with progressive nerve deafness |
| RS1558693760 |
CALM2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS1558697970 |
DNMT3A
|
Health Risk |
Pathogenic |
— |
| RS1558698334 |
RYR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1558699183 |
RPIA
|
Health Risk |
Likely pathogenic |
Deficiency of ribose-5-phosphate isomerase, Deficiency of ribose-5-phosphate isomerase |
| RS1558708492 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Thyroid cancer |
| RS1558710588 |
MYT1L
|
Health Risk |
Likely pathogenic |
— |
| RS1558711346 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1558712349 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Cardiovascular phenotype |
| RS1558712413 |
ALMS1
|
Health Risk |
Pathogenic |
— |
| RS1558715857 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1558715877 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1558716043 |
CRIPT
|
Health Risk |
Pathogenic |
Rothmund-Thomson syndrome type 3, Rothmund-Thomson syndrome type 3 |
| RS1558718572 |
PROC
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS1558727300 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1558728601 |
GFPT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1558735946 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1558737575 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1558738919 |
ABCG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sitosterolemia 2, Sitosterolemia |
| RS1558741321 |
FANCL
|
Health Risk |
Likely pathogenic |
— |
| RS1558749457 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1558750788 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558752379 |
TMEM127
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Pheochromocytoma |
| RS1558752468 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1558756489 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma |
| RS1558756681 |
LOC129934333;TMEM127
|
Health Risk |
Likely pathogenic |
— |
| RS1558756727 |
TMEM127
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS1558761046 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1558762013 |
GFPT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1558771348 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558771751 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558773839 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Congenital myasthenic syndrome 12 |
| RS1558782178 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558783870 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1558787823 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558787893 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558788338 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558792168 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558792256 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558793454 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1558793621 |
EDAR
|
Health Risk |
Pathogenic |
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Ectodermal dysplasia 10A |
| RS1558793736 |
EDAR
|
Health Risk |
Pathogenic |
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Ectodermal dysplasia 10A |
| RS1558796310 |
ABCG8
|
Health Risk |
Pathogenic |
— |
| RS1558805679 |
RAB3GAP1
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558805781 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558805900 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1558806955 |
GGCX
|
Health Risk |
Pathogenic/Likely pathogenic |
GGCX-related disorder, GGCX-related disorder |
| RS1558808357 |
CNGA3
|
Health Risk |
Pathogenic |
— |
| RS1558811557 |
CNGA3
|
Health Risk |
Likely pathogenic |
Achromatopsia 2, Achromatopsia |
| RS1558811634 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1558814135 |
EDAR
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type |
| RS1558814967 |
EDAR
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type |
| RS1558817973 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558820134 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Achromatopsia, Achromatopsia 2 |
| RS1558820471 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1558825869 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1558826853 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1558831442 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS1558845002 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1558863867 |
ABCG8
|
Health Risk |
Likely pathogenic |
— |
| RS1558872822 |
SLC5A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neuronopathy |
| RS1558872865 |
SLC5A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1558875029 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS1558875298 |
REEP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1558879403 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS1558879863 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1558879940 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1558883594 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1558885489 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1558885691 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1558886061 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1558886146 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1558886168 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1558894166 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1558897179 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1558898568 |
REEP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 31, Hereditary spastic paraplegia 31 |
| RS1558898789 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1558903736 |
LOC122756382;LPIN1
|
Health Risk |
Pathogenic |
— |
| RS1558906985 |
SLC25A12
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS1558912774 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1558913371 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1558917090 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS1558925686 |
NRXN1
|
Health Risk |
Likely pathogenic |
— |
| RS1558927163 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1558936154 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1558937172 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS1558939623 |
CHN1
|
Health Risk |
Likely pathogenic |
— |
| RS1558941490 |
GLI2
|
Health Risk |
Pathogenic |
— |
| RS1558948987 |
DCTN1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Perry syndrome |
| RS1558964705 |
ERCC3
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group B, Xeroderma pigmentosum |
| RS1558965303 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1558967217 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1558971345 |
GLS
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 71 |
| RS1558972120 |
GLS
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 71 |
| RS1558973667 |
GLS
|
Health Risk |
Pathogenic |
Global developmental delay, progressive ataxia |
| RS1558986214 |
GLS
|
Health Risk |
Pathogenic |
Infantile cataract, skin abnormalities |
| RS1558988204 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1558992611 |
GALNT3
|
Health Risk |
Likely pathogenic |
Tumoral calcinosis, hyperphosphatemic |
| RS1558993255 |
CNNM4
|
Health Risk |
Pathogenic |
Jalili syndrome, Jalili syndrome |